To Discover the Efficient and Novel Drug Targets in Human Cancers Using CRISPR/Cas Screening and Databases.
Iichiroh OhnishiKouhei YamamotoYuko KinowakiMasanobu KitagawaMorito KurataPublished in: International journal of molecular sciences (2021)
CRISPR/Cas has emerged as an excelle nt gene-editing technology and is used worldwide for research. The CRISPR library is an ideal tool for identifying essential genes and synthetic lethality targeted for cancer therapies in human cancers. Synthetic lethality is defined as multiple genetic abnormalities that, when present individually, do not affect function or survival, but when present together, are lethal. Recently, many CRISPR libraries are available, and the latest libraries are more accurate and can be applied to few cells. However, it is easier to efficiently search for cancer targets with their own screenings by effectively using databases of CRISPR screenings, such as Depmap portal, PICKLES (Pooled In-Vitro CRISPR Knockout Library Essentiality Screens), iCSDB, Project Score database, and CRISP-view. This review will suggest recent optimal CRISPR libraries and effective databases for Novel Approaches in the Discovery and Design of Targeted Therapies.
Keyphrases
- crispr cas
- genome editing
- genome wide
- endothelial cells
- papillary thyroid
- dna methylation
- squamous cell
- induced pluripotent stem cells
- induced apoptosis
- high throughput
- small molecule
- big data
- childhood cancer
- randomized controlled trial
- copy number
- cell cycle arrest
- quality improvement
- gene expression
- squamous cell carcinoma
- endoplasmic reticulum stress
- drug induced
- wild type